Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

FK506 Binding Protein 4, 59kDa (FKBP4) Peptide

FKBP4 Reactivity: Mammalian Host: Synthetic BP, WB, IHC
Catalog No. ABIN936787
  • Target See all FKBP4 products
    FKBP4 (FK506 Binding Protein 4, 59kDa (FKBP4))
    Peptide Type
    Synthetic
    Origin
    Mammalian
    Source
    • 4
    Synthetic
    Application
    Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
    Sequence
    ANMFERLAEE ENKAKAEASS GDHPTDTEMK EEQKSNTAGS QSQVETEA
    Characteristics
    A synthetic peptide for use as a blocking control in assays to test for specificity of FKBP4 antibody,
    Alternative Names: FKBP4 control peptide, FKBP4 antibody Blocking Peptide, Anti-FKBP4 Blocking Peptide, FK506 binding protein 4, 59kDa Blocking Peptide, FKBP52 Blocking Peptide, FKBP59 Blocking Peptide, HBI Blocking Peptide, Hsp56 Blocking Peptide, PPIase Blocking Peptide, p52 Blocking Peptide, FKBP4, FKBP-4, FKBP 4, FKBP-4 Blocking Peptide, FKBP 4 Blocking Peptide
  • Application Notes
    Optimal conditions should be determined by the investigator
    Restrictions
    For Research Use only
  • Format
    Lyophilized
    Reconstitution
    Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
    Buffer
    PBS
    Handling Advice
    Avoid repeated freeze/thaw cycles.
    Storage
    -20 °C
    Storage Comment
    Store at -20 °C long term.
  • Target
    FKBP4 (FK506 Binding Protein 4, 59kDa (FKBP4))
    Background
    This encoded protein is known to associate with phytanoyl-CoA alpha-hydroxylase. It can also associate with two heat shock proteins (hsp90 and hsp70) and thus may play a role in the intracellular trafficking of hetero-oligomeric forms of the steroid hormone receptors. This protein correlates strongly with adeno-associated virus type 2 vectors (AAV) resulting in a significant increase in AAV-mediated transgene expression in human cell lines. Thus this encoded protein is thought to have important implications for the optimal use of AAV vectors in human gene therapy.
    Molecular Weight
    52 kDa
You are here:
Support